1949 - Development of the Bulgarian BCG vaccine against tuberculosis

Pharmacology
Status: yes

About This Innovation

* Rodopska played a pivotal role in developing the Bulgarian BCG vaccine against tuberculosis. * From 1951, intradermal BCG immunization became mandatory for all newborns in Bulgaria, making the country the first in Europe and second in the world after Japan to implement such a policy. * This led to a sharp decline in tuberculosis incidence, especially in children, and reduced mortality rates. * Bulgarian BCG vaccine was tested in WHO reference laboratories in Geneva, Canada, and the USA, and began distribution on three continents. * Her work influenced production and control methods in countries such as Japan, Austria, the USSR, Czechoslovakia, Hungary, and others.

Key Information

Category:
Pharmacology

Completion Status:
yes

Patent Number:
N/A

Patent Information

Patent Number: N/A

Technical Specifications

N/A

Women Behind This Innovation